vs

Side-by-side financial comparison of MARTEN TRANSPORT LTD (MRTN) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

MARTEN TRANSPORT LTD is the larger business by last-quarter revenue ($210.1M vs $151.7M, roughly 1.4× Tarsus Pharmaceuticals, Inc.). MARTEN TRANSPORT LTD runs the higher net margin — 1.8% vs -5.5%, a 7.3% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs -8.8%). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs -8.3%).

Marten Transport, Ltd. is an American trucking company headquartered in Mondovi, Wisconsin. The company offers refrigerated and dry van freight transport services across the United States, Canada, and Mexico.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

MRTN vs TARS — Head-to-Head

Bigger by revenue
MRTN
MRTN
1.4× larger
MRTN
$210.1M
$151.7M
TARS
Growing faster (revenue YoY)
TARS
TARS
+137.2% gap
TARS
128.4%
-8.8%
MRTN
Higher net margin
MRTN
MRTN
7.3% more per $
MRTN
1.8%
-5.5%
TARS
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
-8.3%
MRTN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRTN
MRTN
TARS
TARS
Revenue
$210.1M
$151.7M
Net Profit
$3.7M
$-8.4M
Gross Margin
Operating Margin
2.2%
-5.3%
Net Margin
1.8%
-5.5%
Revenue YoY
-8.8%
128.4%
Net Profit YoY
-34.4%
63.8%
EPS (diluted)
$0.04
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRTN
MRTN
TARS
TARS
Q4 25
$210.1M
$151.7M
Q3 25
$220.5M
$118.7M
Q2 25
$229.9M
$102.7M
Q1 25
$223.2M
$78.3M
Q4 24
$230.4M
$66.4M
Q3 24
$237.4M
$48.1M
Q2 24
$246.2M
$40.8M
Q1 24
$249.7M
$27.6M
Net Profit
MRTN
MRTN
TARS
TARS
Q4 25
$3.7M
$-8.4M
Q3 25
$2.2M
$-12.6M
Q2 25
$7.2M
$-20.3M
Q1 25
$4.3M
$-25.1M
Q4 24
$5.6M
$-23.1M
Q3 24
$3.8M
$-23.4M
Q2 24
$7.9M
$-33.3M
Q1 24
$9.6M
$-35.7M
Operating Margin
MRTN
MRTN
TARS
TARS
Q4 25
2.2%
-5.3%
Q3 25
1.2%
-12.2%
Q2 25
4.2%
-21.6%
Q1 25
2.6%
-33.5%
Q4 24
2.9%
-36.8%
Q3 24
1.8%
-52.3%
Q2 24
4.1%
-81.6%
Q1 24
4.9%
-136.5%
Net Margin
MRTN
MRTN
TARS
TARS
Q4 25
1.8%
-5.5%
Q3 25
1.0%
-10.6%
Q2 25
3.1%
-19.8%
Q1 25
1.9%
-32.1%
Q4 24
2.4%
-34.8%
Q3 24
1.6%
-48.7%
Q2 24
3.2%
-81.6%
Q1 24
3.9%
-129.4%
EPS (diluted)
MRTN
MRTN
TARS
TARS
Q4 25
$0.04
$-0.17
Q3 25
$0.03
$-0.30
Q2 25
$0.09
$-0.48
Q1 25
$0.05
$-0.64
Q4 24
$0.06
$-0.57
Q3 24
$0.05
$-0.61
Q2 24
$0.10
$-0.88
Q1 24
$0.12
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRTN
MRTN
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$43.3M
$417.3M
Total DebtLower is stronger
$72.4M
Stockholders' EquityBook value
$767.6M
$343.4M
Total Assets
$949.8M
$562.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRTN
MRTN
TARS
TARS
Q4 25
$43.3M
$417.3M
Q3 25
$49.5M
$401.8M
Q2 25
$35.1M
$381.1M
Q1 25
$39.9M
$407.9M
Q4 24
$17.3M
$291.4M
Q3 24
$43.0M
$317.0M
Q2 24
$77.2M
$323.6M
Q1 24
$73.7M
$298.5M
Total Debt
MRTN
MRTN
TARS
TARS
Q4 25
$72.4M
Q3 25
$72.3M
Q2 25
$72.1M
Q1 25
$72.0M
Q4 24
$71.8M
Q3 24
$71.7M
Q2 24
$71.6M
Q1 24
$29.9M
Stockholders' Equity
MRTN
MRTN
TARS
TARS
Q4 25
$767.6M
$343.4M
Q3 25
$768.2M
$335.1M
Q2 25
$770.7M
$332.6M
Q1 25
$767.5M
$342.5M
Q4 24
$767.9M
$224.5M
Q3 24
$766.5M
$237.5M
Q2 24
$766.8M
$252.2M
Q1 24
$762.4M
$275.2M
Total Assets
MRTN
MRTN
TARS
TARS
Q4 25
$949.8M
$562.2M
Q3 25
$975.7M
$534.6M
Q2 25
$991.8M
$495.0M
Q1 25
$983.3M
$500.8M
Q4 24
$968.8M
$377.0M
Q3 24
$1.0B
$376.3M
Q2 24
$1.0B
$376.8M
Q1 24
$993.0M
$349.3M
Debt / Equity
MRTN
MRTN
TARS
TARS
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×
Q2 24
0.28×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRTN
MRTN
TARS
TARS
Operating Cash FlowLast quarter
$5.6M
$19.3M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
8.6%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRTN
MRTN
TARS
TARS
Q4 25
$5.6M
$19.3M
Q3 25
$18.5M
$18.3M
Q2 25
$33.2M
$-29.4M
Q1 25
$36.2M
$-20.7M
Q4 24
$23.8M
$-22.2M
Q3 24
$29.5M
$-8.7M
Q2 24
$35.8M
$-14.4M
Q1 24
$45.7M
$-37.8M
Free Cash Flow
MRTN
MRTN
TARS
TARS
Q4 25
$13.0M
Q3 25
$16.3M
Q2 25
$-30.4M
Q1 25
$-21.2M
Q4 24
$-22.3M
Q3 24
$-8.9M
Q2 24
$-15.4M
Q1 24
$-38.0M
FCF Margin
MRTN
MRTN
TARS
TARS
Q4 25
8.6%
Q3 25
13.8%
Q2 25
-29.6%
Q1 25
-27.1%
Q4 24
-33.5%
Q3 24
-18.6%
Q2 24
-37.8%
Q1 24
-137.5%
Capex Intensity
MRTN
MRTN
TARS
TARS
Q4 25
4.2%
Q3 25
1.6%
Q2 25
1.0%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
0.6%
Q2 24
2.5%
Q1 24
0.6%
Cash Conversion
MRTN
MRTN
TARS
TARS
Q4 25
1.51×
Q3 25
8.33×
Q2 25
4.61×
Q1 25
8.35×
Q4 24
4.22×
Q3 24
7.85×
Q2 24
4.54×
Q1 24
4.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRTN
MRTN

Revenue Net Of Fuel Surcharge$91.2M43%
Dedicated$65.9M31%
Brokerage$38.2M18%
Truckload Fuel Surcharge Revenue$14.8M7%
Fuel Surcharge Revenue$9.8M5%

TARS
TARS

Segment breakdown not available.

Related Comparisons